{"title":"Utilización de recursos de atención médica relacionados con la migraña en el mundo real: un análisis de una base de datos administrativa en Colombia","authors":"F. Sobrino, M. Zorro, M.T. Bedoya, M.L. Ramos","doi":"10.1016/j.nrl.2025.502008","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Migraine is a chronic condition characterized by recurrent episodes of severe headache, significantly affecting the functionality of the individuals. The global prevalence and the impact on the quality of life highlight the need for research on its epidemiology and management, especially in specific context such as Colombia, where information on the subject is scarce.</div></div><div><h3>Methods</h3><div>A retrospective descriptive study was conducted with data from the Information System for Social Protection in Colombia (SISPRO) between 2027 and 2021, evaluating the incidence, prevalence, treatment pattern and cost associated with migraine management.</div></div><div><h3>Results</h3><div>293,028 incident cases and 1,711,794 prevalent cases of migraine were identified with a higher incidence and prevalence in women. The use of prophylactic treatments and visits to neurology showed an increasing trend. Although pharmaceutical costs represented the greatest economic burden, they decreased over the course of the study. The annual healthcare cost per patient, expressed in Purchasing Power Parity (PPP) decreased from PPP$110 in 2017 to a minimum of PPP$39 in 2019. The annual pharmacy cost per patient also dropped from PPP$115 in 20</div><div>17 to PPP$64 in 2019.</div></div><div><h3>Conclusions</h3><div>This study highlights migraine as a common condition in Colombia, with a prevalence and management that reflect a need for improved educational and treatment strategies. The research also highlights the importance of national data in understanding and addressing this condition, suggesting the need for public health policies focused on the prevention and optimized management of migraine.</div></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"41 6","pages":"Article 502008"},"PeriodicalIF":2.8000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213485325001872","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Migraine is a chronic condition characterized by recurrent episodes of severe headache, significantly affecting the functionality of the individuals. The global prevalence and the impact on the quality of life highlight the need for research on its epidemiology and management, especially in specific context such as Colombia, where information on the subject is scarce.
Methods
A retrospective descriptive study was conducted with data from the Information System for Social Protection in Colombia (SISPRO) between 2027 and 2021, evaluating the incidence, prevalence, treatment pattern and cost associated with migraine management.
Results
293,028 incident cases and 1,711,794 prevalent cases of migraine were identified with a higher incidence and prevalence in women. The use of prophylactic treatments and visits to neurology showed an increasing trend. Although pharmaceutical costs represented the greatest economic burden, they decreased over the course of the study. The annual healthcare cost per patient, expressed in Purchasing Power Parity (PPP) decreased from PPP$110 in 2017 to a minimum of PPP$39 in 2019. The annual pharmacy cost per patient also dropped from PPP$115 in 20
17 to PPP$64 in 2019.
Conclusions
This study highlights migraine as a common condition in Colombia, with a prevalence and management that reflect a need for improved educational and treatment strategies. The research also highlights the importance of national data in understanding and addressing this condition, suggesting the need for public health policies focused on the prevention and optimized management of migraine.
期刊介绍:
Neurología es la revista oficial de la Sociedad Española de Neurología y publica, desde 1986 contribuciones científicas en el campo de la neurología clínica y experimental. Los contenidos de Neurología abarcan desde la neuroepidemiología, la clínica neurológica, la gestión y asistencia neurológica y la terapéutica, a la investigación básica en neurociencias aplicada a la neurología. Las áreas temáticas de la revistas incluyen la neurologia infantil, la neuropsicología, la neurorehabilitación y la neurogeriatría. Los artículos publicados en Neurología siguen un proceso de revisión por doble ciego a fin de que los trabajos sean seleccionados atendiendo a su calidad, originalidad e interés y así estén sometidos a un proceso de mejora. El formato de artículos incluye Editoriales, Originales, Revisiones y Cartas al Editor, Neurología es el vehículo de información científica de reconocida calidad en profesionales interesados en la neurología que utilizan el español, como demuestra su inclusión en los más prestigiosos y selectivos índices bibliográficos del mundo.